Aurobino Pharma stock is expected to rise to 540 levels based on a rectangle pattern formation and recent upward breakout. The stock is currently trading at support levels and accumulating after a long downtrend. Technical indicators like MACD and RSI are showing upward momentum. The stock price is also trading above its 50 and 200 day moving averages, with a recent crossover seen. It is recommended to buy the stock with targets of 485 and 540 over the next 20 days.